Cognyte Software (NASDAQ:CGNT – Get Free Report) had its price objective lifted by equities researchers at Evercore ISI from $5.00 to $7.50 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has an “in-line” rating on the medical device company’s stock. Evercore ISI’s price objective suggests a potential […]
Cognyte Software (NASDAQ:CGNT – Get Free Report) announced its earnings results on Tuesday. The medical device company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.12, Briefing.com reports. Cognyte Software had a negative net margin of 30.95% and a negative return on equity of 42.06%. The firm had revenue of […]
Legacy Advisors LLC boosted its position in Cognyte Software Ltd. (NASDAQ:CGNT – Free Report) by 8.3% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 82,778 shares of the medical device company’s stock after purchasing an additional 6,339 shares during the quarter. Legacy Advisors […]
Cognyte Software (NASDAQ:CGNT – Get Rating) released its earnings results on Thursday. The medical device company reported ($0.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by ($0.01), Briefing.com reports. Cognyte Software had a negative return on equity of 40.78% and a negative net margin of 30.95%. The business had […]